Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Copenhagen, January 16, 2023 Gemstone Capital will act as financial adviser to Stenocare in connection with their upcoming Units Rights Issue of up to 29.7 mDKK. Gemstone Capital is pleased to announce that it will act as financial adviser for Stenocare in their upcomming Rights Issue of Units. Stenocare is a Danish market-leading company in…
Copenhagen, January 25, 2023 Gemstone Capital A/S acted as sole financial advisor to Spermosens AB. What a breeze, that it IS possible to succeed, even in todays tough market. The ingredients: a great little company, attractive terms and a focused campaign. Now, we look forward to the commercialization of Spermosens’ technology that has the potential…
Välkommen att teckna Units i Spermosens AB Teckningstid: 9 – 23 januari 2023 Observera att vissa banker kan stänga möjligheten för teckning redan torsdagen den 19 januari 📣 Delta i en livepresentation av företaget med VD Ulrik Nilsson med möjlighet att ställa frågor i ett Teams Meeting måndag den 16:e kl 17:00, eller tisdag den…
Invitation to subscribe in Spermosens AB’s Unit Rights Issue Subscription period: 9 – 23 January 2023 Please note that certain banks may close for subscription as early as Thursday, the 19th of January 📣 Join CEO Ulrik Nilsson for a live presentation of the company with Q&A in a Teams Meeting on Monday, the 16th…
Copenhagen, January 1, 2023 To download the 2023 New Years Greeting in English, press here. Gemstone New Year's greeting 2023 p1 Gemstone New Year's greeting 2023 p2
Copenhagen, August 29, 2021 What can we learn from Swedish Investors about Life Science Investments? On Monday the 29th of August our non-executive partner Stefan Lundgren presented at Økonomiske Ugebrevs Life Science Conference. In his presentation, Stefan discussed his view on the dynamics and differences between the Swedish and Danish Life Science space, based on…
Copenhagen, March 2022 With assistance from Gemstone Capital, DecideAct has raised DKK 5,2 million from Jesper Munch, an existing investor in the Company. The issue was priced 10 percent above the ten-day weighted average share price, equal to DKK 8,21 per share. Jens Munch says: “DecideAct is developing well. Right now, times are turbulent,…
Copenhagen, October 2022 Brain+ has successfully completed the exercise window of their IPO warrants of TO1, with a subscription percentage of 82%, which is equivalent to DKK 6,4 million. The Company will thus receive DKK 6,4 million in capital before issuing costs. The Company is pleased with the exercise, which took place at DKK 1,638…
Copenhagen, September 2022 Gemstone Capital is very pleased to announce the latest additions to the team. We welcome Sadjad Hassani and Albert Wanstrup, who join the existing team of analyst team to support our growing portfolio of existing and new clients. Sadjad was previously with PwC and Albert with Nordic Innovators. Welcome to the team!BACK
Copenhagen, August 29, 2021 What can we learn from Swedish Investors about Life Science Investments? On Monday the 29th of August our non-executive partner Stefan Lundgren presented at Økonomiske Ugebrevs Life Science Conference. In his presentation, Stefan discussed his view on the dynamics and differences between the Swedish and Danish Life Science space, based on…